Clinical Trial
In both clinical and non-clinical trials, Aqua-Gard received a palatability (product acceptance) score of 100%. Using the methodologies of Osmolality, Hemocrit (PCV), Mean Corpuscle Hemoglobin (MCH), Mean Platelet Volume (MPV) and Bioelectric Impedance Assessment (BIA), studies found NO adverse physical effects with subjects hydrating with Aqua-Gard versus those hydrating with water. Heart rate, blood pressure, digestion, liver function, cortisol (stress hormone) – all normal. Body weight was slightly less (due to Aqua-Gard’s ability to hydrate equally with less product weight)…and urine production was reduced.
- In both clinical and non-clinical trials, Aqua-Gard palatability (product acceptance) is 100%.
- In a crossover study utilizing ten male subjects ages 18-24 comparing Aqua-Gard by weight directly to water by weight, Aqua-Gard proved sustained hydration at significantly less than 50% of the weight of water.
- Methodology used to prove hydration included Osmolality, Hematocrit (PCV), Mean Corpuscle Hemoglobin(MCH), Mean Platelet Volume (MPV) and Bioelectric Impedance Assessment (BIA).
- Product Safety – liver function by AST and ALT enzymes (no difference). These enzymes in both the water group and Aqua-Gard group were stable across the day. Cortisol (stress hormone) showed no significant difference in the water group vs. the Aqua-Gard group across the day.
- Physical Effects – there are no adverse physical effects associated with Aqua-Gard. Heart rate normal, blood pressure normal, no digestive discomfort or abnormalities. Body weight – both groups gained weight. As expected, the water group gained more weight. By product design, Aqua-Gard urine volume was less and more concentrated.